Cargando…
Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424841/ https://www.ncbi.nlm.nih.gov/pubmed/30887766 http://dx.doi.org/10.3802/jgo.2019.30.e68 |
| _version_ | 1783404725591343104 |
|---|---|
| author | Bogani, Giorgio Raspagliesi, Francesco |
| author_facet | Bogani, Giorgio Raspagliesi, Francesco |
| author_sort | Bogani, Giorgio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6424841 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64248412019-05-01 Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer? Bogani, Giorgio Raspagliesi, Francesco J Gynecol Oncol Correspondence Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019-03-04 /pmc/articles/PMC6424841/ /pubmed/30887766 http://dx.doi.org/10.3802/jgo.2019.30.e68 Text en Copyright © 2019. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correspondence Bogani, Giorgio Raspagliesi, Francesco Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer? |
| title | Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer? |
| title_full | Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer? |
| title_fullStr | Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer? |
| title_full_unstemmed | Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer? |
| title_short | Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer? |
| title_sort | does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer? |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424841/ https://www.ncbi.nlm.nih.gov/pubmed/30887766 http://dx.doi.org/10.3802/jgo.2019.30.e68 |
| work_keys_str_mv | AT boganigiorgio doestheadoptionofsentinelnodemappingallowtodesignanewtrialtestingthevalueofretroperitonealstaginginendometrialcancer AT raspagliesifrancesco doestheadoptionofsentinelnodemappingallowtodesignanewtrialtestingthevalueofretroperitonealstaginginendometrialcancer |